Artificial Intelligence in Medicine: Competition Improves AI’s Accuracy in Grading Prostate Cancer
According to Swedish and Dutch experts, there’s often a bias problem in Artificial Intelligence (AI) programs designed to grade prostate cancer (PCa) aggressiveness. That is, those who develop algorithms that are trained on a particular set of data are also the people who evaluate their accuracy. Where’s the objectivity in that method? There’s a risk keep reading